Innocan Pharma announced the successful completion of a large-scale production of exosomes. Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the ...
Read More »
InnoCan Pharma announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement with Ramot at Tel Aviv University to collaborate with Tel Aviv university to develop a novel, revolutionary...
Read More »
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple...
Read More »
Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by three core symptoms that include social interaction deficits, cognitive inflexibility, and communication disorders...
Read More »
Oral cancer (OC) patients are at high risk to develop recurrent disease or secondary primary cancers with no available biomarkers to detect these events until a visible lesion is readily present and diagnosed by biopsy. Exosomes secreted by cancer cells ...
Read More »
TAU researcher advances novel strategy to fight cancer by shoring up the immune system Two years ago, Prof. Eshel Ben-Jacob of Tel Aviv University‘s School of Physics and Astronomy and Rice University’s Center for Theoretical Biological Physics made the startling ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
